BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells

Journal of Clinical Investigation

Volumn 97, Issue 6, 1996, Pages 1422-1428

  Giardino, Ida ^a   Edelstein, Diane ^a   Brownlee, Michael ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

antioxidants; diabetes; glucose; peroxidation; reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BASIC FIBROBLAST GROWTH FACTOR; DEFEROXAMINE; DIMETHYL SULFOXIDE; FREE RADICAL; GLUCOSE; HYDROXYL RADICAL; MONOCLONAL ANTIBODY; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CATTLE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENDOTHELIUM CELL; GLYCATION; HYPERGLYCEMIA; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0030009314     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118563     Document Type: Article

References (48)

1. Nathan, D. 1994. Relationship between metabolic control and long term complications of diabetes. in Joslin's Diabetes Mellitus, 13th ed. C.R. Kahn and G.C Weir, editors. Lea and Febiger, Philadelphia, PA 620-630.
2. The diabetes control and complications trial research group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329.977-986.
3. Kuusisto, J., L. Mykkanen, K. Pyorala, and M. Laakso. 1994. NIDDM and its metabolic control predict heart disease in elderly subjects. Diabetes. 43: 960-967.
4. Kinoshita, J.H. 1990. A thirty year journey in the polyol pathway. Exp. Eye Res. 50:567.
5. DeRubertis, F R., and P.A Craven 1994. Activation of protein kinase C in glomerular cells in diabetes, mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes. 43:1-8.
6. King, G.L., T. Shiba, J. Oliver, T. Inoguchi, and S.E. Bursell 1994. Cellular and molecular abnormalities in the vascular endothehum of diabetes mellitus. Ann. Rev. Med. 45:179-188.
7. Williamson, J R , K Chang, M. Frangos, K.S. Hasan, Y. Ido, T. Kawamura. J R Nyengaard, M. van den Enden, C. Kilo, and R.G. Tilton. 1993 Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813.
8. Bucala, R , Z. Makita, T. Koschinsky, A Cerami, and H. Vlassara 1993. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA. 90:6434-6438.
9. Vlassara, H., R. Bucala, and L. Striker. 1994. Pathogenic effects of AGE's. Biochemical, biologic and clinical implications for diabetes and aging. Lab. Invest. 70:138-151.
10. Brownlee, M., A. Cerami. and H. Vlassara 1988. Advanced glycosylation endproducts in tissue and the biochemical basis of complications. (Beth Israel Seminar in Medicine) N. Engl. J. Med. 318:1315-1321.
11. Makita, Z., H. Vlassara, E. Rayfield, K. Cartwright, E Friedmann, R. Rody, A Cerami, and R Bucala. 1992. Hemoglobin-AGE: a circulating marker of advanced glycosylation Science (Wash. DC). 258:651-653.
12. Giardino, L, D. Edelstein, and M. Brownlee. 1994. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J Clin. Invest. 94110-117.
13. Monnier, V. 1988. The Malliard Reaction in Aging, Diabetes, and Nutrition, an NIH Conference. J.W. Baynes and V. Monnier editors. Alan R. Liss, New York. 1-22.
14. Fu, M.-X., K.J. Wells-Knecht, J.A. Blackledge,T.J. Lyons, S.R Thorpe, and J.W. Baynes. 1994. Glycation, glycoxidation, and cross-linking of collagen by glucose kinetics, mechanisms, and inhibition of late stages of the maillard reaction. Diabetes. 43:676-583.
15. Presta, M., J.A.M. Mayer, M. Rusnati, and G. Ragnotti. 1988. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form J Cell Physiol. 140.68-74.
16. Boissy, R.E., L.S. Trinkle, and J.J. Nordlund 1989. Separation of pigmented and albino melanocytes and concomitant evaluation of endogenous peroxide content using flow cytometry. Cytometry. 10:779-787.
17. Hensley, H., J.M. Carney, M.P. Mattson, M. Aksenova, M. Harris, J.F. Wu, R.A. Floyd, and D.A. Butterfield. 1994. A model for B-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sci USA. 91:3270-3274.
18. Dennery, P.A., C.M. Kramer, and S.E. Alpert. 1990. Effect of fatty acid profiles and susceptibility of cultured rabbit tracheal epithelial cells to hyperoxic injury. Am J. Respir. Cell Mol. Biol. 3:137-144
19. Bischoff, J., and H.P. Lodish. 1987. Two asialoglycoprotein receptor polypeptides in human hepatoma cells. J. Biol. Chem. 262:11825-11832.
20. Horiuchi, S., N. Araki, and Y. Morino. 1991. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol Chem. 266:7329-7332.
21. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond). 227:680-685.
22. Araki, N., N. Ueno, B. Chakrabarti, Y. Morino, and S. Horiuchi. 1992. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J. Biol. Chem. 267:10211-10214.
23. Gebicki, J.M., and M Hicks. 1976. Preparation and properties of vesicles enclosed by fatty acid membranes. Chem. and Phys. Lipids 16:142-160.
24. Hunt, J.V., J.S. Simpson and R T. Dean 1988. Hydroperoxide-mediated fragmentation of proteins. Biochem. J. 250:87-93.
25. Palinski, W., S. Yla-Herttuala, M.E. Rosenfeld, S.W. Butler, S.A. Socher, S. Parthasarathy, L.K. Curtiss, and J.L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of Low Density Lipoprotein. Arteriosclerosis. 10:325-335
26. Starr, R.G., B. Lu, and H. Federoff. 1991. Functional characterization of the rat GAP-43 promoter Brain Res. 638:211-220.
27. Geller, A., and A. Freese. 1990. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in a stale expression of Eschenchia coli beta-galactosidase Proc. Natl. Acad. Sci. USA. 87:1149-1153.
28. Federoff, H.J , M.D. Geschwind, A L. Galler, and I.A. Kessler. 1992. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc. Natl Acad. Sci USA 89:1636-1640
29. Bergold, P.J , P. Casaccia-Bonnefil, X L. Zeng, and H.J Federoff. 1993. Transsynaptic neuronal loss induced hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc. Natl Acad. Sci. USA. 90:6165-6169.
30. Wolff, S.P., and R.T. Dean. 1987. Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes. Biochem. J. 245:243-250.
31. Hunt, J.V., R.T. Dean, and S.P. Wolf. 1988. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J 256:205-212.
32. Ku, R.H., and R.E. Billings. 1986. The role of mitochondrial glutathione and cellular protein sulfhydryls in formaldehyde toxicity in glutathione-depleted rat hepatocytes. Arch. Biochem. Biophys. 247:183-189.
33. Palinski, W., T. Koschinsky, S W. Butler, E. Milier, H. Vlassara, A Cerami, and J.L Witztum. 1995. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vase. Biol. 15 571-582.
34. Hockenbery, D.M., Z.N. Oltvai, X.-M. Yin, C.L. Milliman, and S J. Korsmeyer, 1993. Bcl-2 functions in a antioxidant pathway to prevent apoptosis. Cell 75:241-251.
35. Malhortra, O.P., D.K. Srivastava, A.M. Kayastha, and A. Srinivasan. 1993, Inactivation of glyceralddhyde-3-phosphate dehydrogenase with SH-reagents and its relationship to the protein quaternary structure. Indian Journal of Biochemistry & Biophysics. 30 264-269.
36. Shivakumar, B.R., and V. Ravindranath 1992. Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-mduced neurotoxicity. Biochem. Pharmacol. 43:263-269.
37. Mullarkey, C.J., D. Edelstein, and M. Brownlee. 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173:932-939.
38. 2-generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP. Biochim. Biophys. Acta. 1043:27-33.
39. Jiang, Z.Y., A.C.S. Woolard, and S.P. Wolff. 1990. Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 268:69-71.
40. Hunt, J.V., M.A. Bottoms, and M.J. Mitchinson. 1993. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Biochem J. 291:529-535.
41. Wells-Knecht, K.J., D V. Zyzak, J.E. Litchfield, S.R. Thorpe, and J.W. Baynes. 1995. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 34:3702-3709.
42. Szwergold, B.S., F. Kappler, and T.R. Brown. 1990. Identification of fructose 3-phosphate in the lens of diabetic rats. Science (Wash. DC). 247:451-454.
43. Franzmi, E., H. Sellak, J. Hakim, and C. Pasquier. 1994. Comparative sugar degradation by (OH) produced by the iron-driven Fenton reaction and gamma radiolysis. Arch. Biochem. Biophys. 309:261-265.
44. Gutteridge, J.M. 1981. Thiobarbituric acid-reactivity following iron-dependent free-radical damage to amino acids and carbohydrates. FEBS Lett 128:343-346.
45. Halkwell, B., and J.M. Gutteridge. 1981. Formation of a thiobarbituricacid-reactive substance from deoxyribose in the presence of iron salts. The role of superoxide and hydroxyl radicals. FEBS Lett. 128:347-352.
46. Gutteridge, J.M. 1984. Reactivity of hydroxyl and hydroxyl-like radicals discriminated by release of thiobarbituric acid-reactive material from deoxy sugars, nucleosides and benzoate. Biochem. J. 224:761-767.
47. Hammes, H.P., D. Strodter, A. Weiss, R.G. Bretzel, K. Federlin, and M. Brownlee. 1995 Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model. Diabetologia. 38:656-660.
48. Brownlee, M. 1995. Advanced protein glycosylation in diabetes and aging. Annu. Rev Med 46:223-234.